Delivery Order SPE2DB22D3011-SPE2DB25FQ2CZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, valued at $2,954.20. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a non-competitive set-aside. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $17,648.12 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack) with a completion date of August 26, 2025. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,545.04 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This firm fixed price, competitively awarded delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The contractor will perform from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units) with a ceiling value of $1,308.27. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of August 13, 2025. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,594.64 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a firm fixed-price delivery order under a non-set-aside competition. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,273.25 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $2,945.34 to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector (2-pack) with an ultimate completion date of September 29, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $3,401.68. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract will be performed in...
- The Defense Logistics Agency awarded a $3,626.12 delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with completion scheduled for June 23, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Epinephrine 0.15 mg auto-injector 2-packs, with a ceiling value of $1,144.77 and an ultimate completion date of September 23, 2025. This is a firm fixed-price delivery order executed without a set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing under its significant Indefinite...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2CZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,845.10 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs. The contract is a firm fixed price delivery order with no set-aside designation, representing a competitive award. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for the Defense Logistics Agency and related military healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling federal medical supply needs across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This particular order for epinephrine auto-injectors represents routine pharmaceutical procurement to support Defense Health Agency operations and other government healthcare beneficiaries through the established pharmaceutical prime vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/6/25 |